Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Applied Therapeutics (APLT) Assets (2023 - 2025)

Historic Assets for Applied Therapeutics (APLT) over the last 3 years, with Q3 2025 value amounting to $34.4 million.

  • Applied Therapeutics' Assets fell 6774.39% to $34.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.4 million, marking a year-over-year decrease of 6774.39%. This contributed to the annual value of $86.7 million for FY2024, which is 5810.0% up from last year.
  • Applied Therapeutics' Assets amounted to $34.4 million in Q3 2025, which was down 6774.39% from $37.3 million recorded in Q2 2025.
  • Over the past 5 years, Applied Therapeutics' Assets peaked at $151.2 million during Q1 2024, and registered a low of $30.0 million during Q1 2023.
  • For the 3-year period, Applied Therapeutics' Assets averaged around $70.4 million, with its median value being $54.8 million (2023).
  • In the last 5 years, Applied Therapeutics' Assets skyrocketed by 40404.61% in 2024 and then crashed by 7077.59% in 2025.
  • Applied Therapeutics' Assets (Quarter) stood at $54.8 million in 2023, then skyrocketed by 58.1% to $86.7 million in 2024, then plummeted by 60.35% to $34.4 million in 2025.
  • Its last three reported values are $34.4 million in Q3 2025, $37.3 million for Q2 2025, and $56.9 million during Q1 2025.